Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 390.00
+0.50 (0.13%)
Oct 31, 2025, 2:31 PM CST
Sunmax Biotechnology Market Cap
Sunmax Biotechnology has a market cap or net worth of 21.24 billion as of October 31, 2025. Its market cap has increased by 48.01% in one year.
Market Cap
21.24B
Enterprise Value
20.15B
Revenue
1.95B
Ranking
n/a
PE Ratio
30.42
Stock Price
390.00
Market Cap Chart
Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.24B, an increase of 1,328.34%. That is a compound annual growth rate of 18.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 21.24B | 39.29% |
| Dec 30, 2024 | 15.25B | 37.25% |
| Dec 29, 2023 | 11.11B | 50.00% |
| Dec 30, 2022 | 7.41B | 64.65% |
| Dec 30, 2021 | 4.50B | 2.61% |
| Dec 31, 2020 | 4.38B | 0.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |